Arkolith/Insider Trading/AVBP/Form 4

Healy James

DirectorArriVent Biopharma, Inc. (AVBP) · full profile →Form 4 · filed Jan 31, 2024
Net Buying
Open-Market Buys
$8.0M
Open-Market Sells
$0
Net Open-Market Flow
$8.0M
Transactions
3
2 non-derivative · 1 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
Jan 30, 2024Conversion(C)1.3M——1.3M
Jan 30, 2024Buy(P)444K$18.00$8.0M1.7M

Derivative Transactions (Table II)

DateActionSharesPriceValueOwned After
Jan 30, 2024Conversion(C)1.3M——0

Transaction Codes

C
Conversion of a derivative
P
Open-market purchase

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001104659-24-008796) within minutes of acceptance. Every field above traces to the original document. Verify it directly:

View original filing on SEC.govRaw Form 4 XML